A researcher is testing a new drug developed to treat diabet…
A researcher is testing a new drug developed to treat diabetes. Participants are randomly assigned to a treatment and control group. Unfortunately, due to some severe side effects, a group of participants asks and are granted permission to be moved to the control conditions. This results in a Type I error as the drug appears to be more effective than it really is; the only participants taking the drug are the ones benefitting the most. To avoid a possible Type I error, the researchers could use which of the following designs:
Read Details